About

NANDA P.B.A. KUMAR, J.D., Ph.D.

Nanda Kumar

LAW OFFICES OF NANDA P.B.A. KUMAR, LLC

1589 Old Trenton Road
Princeton Junction, NJ 08550

Tel: (609) 987-2282
Cell: (215) 880-4113
Fax: (844) 684-3395

Email: [email protected]

Bar Admissions

  • Pennsylvania
  • New Jersey
  • U.S. Patent and Trademark Office

Court Admissions

  • All State Courts - Pennsylvania
  • All State Courts - New Jersey
  • U.S. District Court - Eastern District of Pennsylvania
  • U.S. District Court - District of New Jersey

Practice Focus

Patent Prosecution and analysis

IP and Life Sciences Transactions

Trademark Prosecution and Portfolio Management

Patent Litigation

Employment History

2015
Law Offices of Nanda P.B.A Kumar, LLC, Princeton, New Jersey

1999
Reed Smith LLP, Philadelphia (Partner from January 2007 – August 2015)

1997
Dechert LLP, Princeton, New Jersey (Law Clerk)

1996
NovaFlora, Inc., Philadelphia - Senior Scientist

1995
Phytotech, Inc., New Jersey - Research Scientist

1992
Center for Agricultural Molecular Biology, Rutgers University, New Jersey - Post-Doctoral Fellowship

1990
Tata Energy Research Institute, New Delhi, India - Post-Doctoral Fellowship

1989
Biotechnology Center of Indian Agricultural Research Institute, New Delhi, India - Post-Doctoral Fellowship

Nanda Kumar Law

Technical Background

Prior to entering the law field, Dr Kumar held Senior Scientist research positions in the U.S. industry and was a Post-Doctoral Research Fellow at The Center for Agricultural Molecular Biology, Rutgers University; The Biotechnology Center of Indian Agricultural Research Institute; and The Tata Energy Research Institute. His scientific background focused primarily on biology, biochemistry, genetics, biotechnology, and molecular biology.

Activities

  • Contributing Author, Black’s Law Dictionary, Abridged Eighth Edition, 2005
  • “Key IP Issues related to Open Innovation Collaboration,” Speaker BioJapan 2007, Yokohama, Sept. 19-21, 2007
  • “Potential IP-Related Obstacles As Adult Stem Cell Therapies Progress Toward The Market,” speaker and panel discussion moderator, Phacilitate Cell & Gene Therapy Forum 2007, Baltimore, Jan. 22-24, 2007
  • “Intellectual Property Rights and Due Diligence,” BioAsia 2005, Hyderabad, India, Feb. 10-12, 2005
  • “Patents and Patenting Biotech Inventions in the U.S.,” International Conference on Innovation & Intellectual Property Rights Strategy, Hyderabad, India, Sept. 12-13, 2002
  • “Drug Development Collaboration Agreements – Intellectual Property Considerations,” BioAsia 2008, Hyderabad, India, Feb. 7-9, 2008
  • “Drug Products Based on Small Molecules and Biologics – Exclusivity Incentives,” Pharma Legal & Compliance Summit 2013, Mumbai, India, September 27, 2013
  • Recipient of “Leadership Excellence in the Law Award 2014” conferred by the Pennsylvania Diversity Council. The award recognizes attorneys in the greater Philadelphia region who have demonstrated outstanding leadership, resolve, and achievements for the benefit of their clients and communities
  • “USFDA Compliance Issues: Backup Strategy” in Keynote Session: Demystifying Compliance, Pharma Legal & Compliance Summit 2015, Mumbai, India, October 16, 2015
  • “Section 101 and Its Implications on Biotechnology and Pharmaceuticals” panel session moderator, World Intellectual Property Forum, November 14-16, 2018, New Delhi.
  • “Invalidity issues explored by pharmaceutical patent type,” presentation in a seminar series on WINNING U.S. PHARMACEUTICAL PATENT ACTIONS AND PTAB PROCEEDINGS by Maynard Cooper & Gale in India, February 4-8, 2019.